Correspondence 0001193125-23-249198 from Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: Oct. 2, 2023 · CIK: 0001811115 · Accession: 0001193125-23-249198
AI Filing Summary & Sentiment
File numbers found in text: 333-274733
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Registration Statement on Form S-3; File No. 333-274733
Re: Renalytix plc
Dear Sir or Madam:
Renalytix plc (the “Registrant”) hereby withdraws its request, dated September 29, 2023, that the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to September 29, 2023, at 4:00 p.m. Eastern Time. The Registrant intends to submit a revised acceleration request for the Registration Statement at a later date.
Please contact Katie Kazem of Cooley LLP at (703) 456 8043, counsel to the Company, if there are any questions regarding this matter.
Very truly yours,
RENALYTIX PLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP October 2, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Renalytix plc Registration Statement on Form S-3; File No. 333-274733 Dear Sir or Madam: Renalytix plc (the “Registrant”) hereby withdraws its request, dated September 29, 2023, that the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to September 29, 2023, at 4:00 p.m. Eastern Time. The Registrant intends to submit a revised acceleration request for the Registration Statement at a later date. Please contact Katie Kazem of Cooley LLP at (703) 456 8043, counsel to the Company, if there are any questions regarding this matter. Very truly yours, RENALYTIX PLC By: /s/ James McCullough James McCullough Chief Executive Officer